ENTRY       mmu05033                    Pathway
NAME        Nicotine addiction - Mus musculus (mouse)
DESCRIPTION Nicotine is one of the main psychoactive ingredients in tobacco that contributes to the harmful tobacco smoking habit. A common feature of addictive drugs, including nicotine, is that they increase dopamine (DA) release in the nucleus accumbens (NAc). The principal dopaminergic projections to NAc arise from neurons in the ventral tegmental area (VTA). In the VTA, alpha6- and alpha4beta2-containing nAChRs (alpha6*-AChRs and alpha4beta2*-AChRs, respectively) are located on GABAergic terminals and provide inhibitory inputs onto DAergic neuons, while alpha7*-nAChRs are located on glutamatergic terminals and activation of these receptors enhances glutamate release and increases excitability of DAergic neurons. Nicotine acts as an agonist to activate and desensitize these nicotinic acetylcholine receptors (nAChRs). After a short exposure to nicotine, alpha6*- and alpha4beta2*- nAChRs on GABAergic afferents are desensitized, decreasing GABA release and decreasing local inhibition of DA neurons. But the alpha7*-nAChRs on glutamatergic afferents remain active and enhance glutamate excitation of the DA neurons, leading to increased DA release in the NAc -and so facilitate the reinforcing effects of nicotine.
CLASS       Human Diseases; Substance dependence
PATHWAY_MAP mmu05033  Nicotine addiction
DBLINKS     GO: 0035094
ORGANISM    Mus musculus (mouse) [GN:mmu]
GENE        22348  Slc32a1; solute carrier family 32 (GABA vesicular transporter), member 1 [KO:K15015]
            11440  Chrna6; cholinergic receptor, nicotinic, alpha polypeptide 6 [KO:K04808]
            12286  Cacna1a; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit [KO:K04344]
            12287  Cacna1b; calcium channel, voltage-dependent, N type, alpha 1B subunit [KO:K04849]
            11438  Chrna4; cholinergic receptor, nicotinic, alpha polypeptide 4 [KO:K04806]
            11444  Chrnb2; cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) [KO:K04813]
            14394  Gabra1; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 [KO:K05175]
            14395  Gabra2; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 [KO:K05175]
            14396  Gabra3; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 [KO:K05175]
            14397  Gabra4; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4 [KO:K05175]
            110886  Gabra5; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5 [KO:K05175]
            14399  Gabra6; gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6 [KO:K05175]
            14400  Gabrb1; gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 [KO:K05181]
            14402  Gabrb3; gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 [KO:K05181]
            14401  Gabrb2; gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 [KO:K05181]
            14405  Gabrg1; gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 [KO:K05186]
            14406  Gabrg2; gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 [KO:K05186]
            14407  Gabrg3; gamma-aminobutyric acid (GABA) A receptor, subunit gamma 3 [KO:K05186]
            14403  Gabrd; gamma-aminobutyric acid (GABA) A receptor, subunit delta [KO:K05184]
            14404  Gabre; gamma-aminobutyric acid (GABA) A receptor, subunit epsilon [KO:K05185]
            57249  Gabrq; gamma-aminobutyric acid (GABA) A receptor, subunit theta [KO:K05192]
            216643  Gabrp; gamma-aminobutyric acid (GABA) A receptor, pi [KO:K05189]
            14408  Gabrr1; gamma-aminobutyric acid (GABA) C receptor, subunit rho 1 [KO:K05190]
            14409  Gabrr2; gamma-aminobutyric acid (GABA) C receptor, subunit rho 2 [KO:K05190]
            328699  Gabrr3; gamma-aminobutyric acid (GABA) receptor, rho 3 [KO:K05190]
            140919  Slc17a6; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 [KO:K12302]
            216227  Slc17a8; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 [KO:K12302]
            72961  Slc17a7; solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 [KO:K12302]
            11441  Chrna7; cholinergic receptor, nicotinic, alpha polypeptide 7 [KO:K04809]
            14810  Grin1; glutamate receptor, ionotropic, NMDA1 (zeta 1) [KO:K05208]
            14811  Grin2a; glutamate receptor, ionotropic, NMDA2A (epsilon 1) [KO:K05209]
            14812  Grin2b; glutamate receptor, ionotropic, NMDA2B (epsilon 2) [KO:K05210]
            14813  Grin2c; glutamate receptor, ionotropic, NMDA2C (epsilon 3) [KO:K05211]
            14814  Grin2d; glutamate receptor, ionotropic, NMDA2D (epsilon 4) [KO:K05212]
            242443  Grin3a; glutamate receptor ionotropic, NMDA3A [KO:K05213]
            170483  Grin3b; glutamate receptor, ionotropic, NMDA3B [KO:K05214]
            14799  Gria1; glutamate receptor, ionotropic, AMPA1 (alpha 1) [KO:K05197]
            14800  Gria2; glutamate receptor, ionotropic, AMPA2 (alpha 2) [KO:K05198]
            53623  Gria3; glutamate receptor, ionotropic, AMPA3 (alpha 3) [KO:K05199]
            14802  Gria4; glutamate receptor, ionotropic, AMPA4 (alpha 4) [KO:K05200]
COMPOUND    C00025  L-Glutamate
            C00076  Calcium cation
            C00334  4-Aminobutanoate
            C00698  Cl-
            C00745  Nicotine
            C01330  Sodium cation
            C01996  Acetylcholine
REFERENCE   PMID:12436424
  AUTHORS   Mansvelder HD, McGehee DS
  TITLE     Cellular and synaptic mechanisms of nicotine addiction.
  JOURNAL   J Neurobiol 53:606-17 (2002)
            DOI:10.1002/neu.10148
REFERENCE   PMID:15661626
  AUTHORS   Wonnacott S, Sidhpura N, Balfour DJ
  TITLE     Nicotine: from molecular mechanisms to behaviour.
  JOURNAL   Curr Opin Pharmacol 5:53-9 (2005)
            DOI:10.1016/j.coph.2004.12.002
REFERENCE   PMID:19669944
  AUTHORS   Mao D, McGehee DS
  TITLE     Nicotine and behavioral sensitization.
  JOURNAL   J Mol Neurosci 40:154-63 (2010)
            DOI:10.1007/s12031-009-9230-7
REFERENCE   PMID:19184650
  AUTHORS   Barik J, Wonnacott S
  TITLE     Molecular and cellular mechanisms of action of nicotine in the CNS.
  JOURNAL   Handb Exp Pharmacol 173-207 (2009)
            DOI:10.1007/978-3-540-69248-5_7
REFERENCE   PMID:19498417
  AUTHORS   Yang KC, Jin GZ, Wu J
  TITLE     Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.
  JOURNAL   Acta Pharmacol Sin 30:740-51 (2009)
            DOI:10.1038/aps.2009.63
REFERENCE   PMID:14747518
  AUTHORS   Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani JA
  TITLE     Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction.
  JOURNAL   Learn Mem 11:60-9 (2004)
            DOI:10.1101/lm.70004
REFERENCE   PMID:12716925
  AUTHORS   Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA
  TITLE     Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.
  JOURNAL   J Neurosci 23:3176-85 (2003)
            DOI:10.1523/JNEUROSCI.23-08-03176.2003
REFERENCE   PMID:19434058
  AUTHORS   Xi ZX, Spiller K, Gardner EL
  TITLE     Mechanism-based medication development for the treatment of nicotine dependence.
  JOURNAL   Acta Pharmacol Sin 30:723-39 (2009)
            DOI:10.1038/aps.2009.46
REFERENCE   PMID:14708004
  AUTHORS   Laviolette SR, van der Kooy D
  TITLE     The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour.
  JOURNAL   Nat Rev Neurosci 5:55-65 (2004)
            DOI:10.1038/nrn1298
REFERENCE   PMID:20485364
  AUTHORS   Changeux JP
  TITLE     Nicotine addiction and nicotinic receptors: lessons from genetically modified mice.
  JOURNAL   Nat Rev Neurosci 11:389-401 (2010)
            DOI:10.1038/nrn2849
REFERENCE   PMID:17009926
  AUTHORS   Dani JA, Bertrand D
  TITLE     Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
  JOURNAL   Annu Rev Pharmacol Toxicol 47:699-729 (2007)
            DOI:10.1146/annurev.pharmtox.47.120505.105214
REFERENCE   PMID:11906697
  AUTHORS   Mansvelder HD, Keath JR, McGehee DS
  TITLE     Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.
  JOURNAL   Neuron 33:905-19 (2002)
            DOI:10.1016/S0896-6273(02)00625-6
REFERENCE   PMID:18723034
  AUTHORS   O'Dell LE
  TITLE     A psychobiological framework of the substrates that mediate nicotine use during adolescence.
  JOURNAL   Neuropharmacology 56 Suppl 1:263-78 (2009)
            DOI:10.1016/j.neuropharm.2008.07.039
REFERENCE   PMID:20833261
  AUTHORS   Ortells MO, Arias HR
  TITLE     Neuronal networks of nicotine addiction.
  JOURNAL   Int J Biochem Cell Biol 42:1931-5 (2010)
            DOI:10.1016/j.biocel.2010.08.019
REFERENCE   PMID:16251989
  AUTHORS   Dani JA, Harris RA
  TITLE     Nicotine addiction and comorbidity with alcohol abuse and mental illness.
  JOURNAL   Nat Neurosci 8:1465-70 (2005)
            DOI:10.1038/nn1580
REFERENCE   PMID:18640919
  AUTHORS   Markou A
  TITLE     Review. Neurobiology of nicotine dependence.
  JOURNAL   Philos Trans R Soc Lond B Biol Sci 363:3159-68 (2008)
            DOI:10.1098/rstb.2008.0095
REFERENCE   PMID:15165747
  AUTHORS   Dajas-Bailador F, Wonnacott S
  TITLE     Nicotinic acetylcholine receptors and the regulation of neuronal signalling.
  JOURNAL   Trends Pharmacol Sci 25:317-24 (2004)
            DOI:10.1016/j.tips.2004.04.006
REL_PATHWAY mmu04724  Glutamatergic synapse
            mmu04727  GABAergic synapse
            mmu04728  Dopaminergic synapse
KO_PATHWAY  ko05033
///
